Kuramoto K - Search Results

1

The BECN1-BCL2 complex regulates insulin secretion and storage in mice.

Kuramoto K, He C. Kuramoto K, et al. Autophagy. 2018;14(11):2026-2028. doi: 10.1080/15548627.2018.1502566. Epub 2018 Aug 21. Autophagy. 2018. PMID: 30081744 Free PMC article.

2

Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids.

Kuramoto K, Wang N, Fan Y, Zhang W, Schoenen FJ, Frankowski KJ, Marugan J, Zhou Y, Huang S, He C. Kuramoto K, et al. Autophagy. 2016 Sep;12(9):1460-71. doi: 10.1080/15548627.2016.1187367. Epub 2016 Jun 15. Autophagy. 2016. PMID: 27305347 Free PMC article.

3

Autophagy Differentially Regulates Insulin Production and Insulin Sensitivity.

Yamamoto S, Kuramoto K, Wang N, Situ X, Priyadarshini M, Zhang W, Cordoba-Chacon J, Layden BT, He C. Yamamoto S, et al. Among authors: kuramoto k. Cell Rep. 2018 Jun 12;23(11):3286-3299. doi: 10.1016/j.celrep.2018.05.032. Cell Rep. 2018. PMID: 29898399 Free PMC article.

4

The secretory function of BECN1 in metabolic regulation.

Kuramoto K, He C. Kuramoto K, et al. Autophagy. 2021 Oct;17(10):3262-3263. doi: 10.1080/15548627.2021.1953849. Epub 2021 Jul 19. Autophagy. 2021. PMID: 34281478 Free PMC article.

5

The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding.

Kuramoto K, Kim YJ, Hong JH, He C. Kuramoto K, et al. Cell Rep. 2021 May 25;35(8):109184. doi: 10.1016/j.celrep.2021.109184. Cell Rep. 2021. PMID: 34038729 Free PMC article.

6

An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system.

Kim YJ, Kong Q, Yamamoto S, Kuramoto K, Huang M, Wang N, Hong JH, Xiao T, Levine B, Qiu X, Zhao Y, Miller RJ, Dong H, Meltzer HY, Xu M, He C. Kim YJ, et al. Among authors: kuramoto k. Sci Adv. 2021 Feb 19;7(8):eabc8310. doi: 10.1126/sciadv.abc8310. Print 2021 Feb. Sci Adv. 2021. PMID: 33608268 Free PMC article.

7

Degradative and Non-Degradative Roles of Autophagy Proteins in Metabolism and Metabolic Diseases.

Kuramoto K, He C. Kuramoto K, et al. Front Cell Dev Biol. 2022 May 13;10:844481. doi: 10.3389/fcell.2022.844481. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35646940 Free PMC article. Review.

8

Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.

Seino M, Okada M, Sakaki H, Takeda H, Watarai H, Suzuki S, Seino S, Kuramoto K, Ohta T, Nagase S, Kurachi H, Kitanaka C. Seino M, et al. Among authors: kuramoto k. Oncol Rep. 2016 Jan;35(1):593-601. doi: 10.3892/or.2015.4377. Epub 2015 Nov 2. Oncol Rep. 2016. PMID: 26534836

9

GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.

Sakaki H, Okada M, Kuramoto K, Takeda H, Watarai H, Suzuki S, Seino S, Seino M, Ohta T, Nagase S, Kurachi H, Kitanaka C. Sakaki H, et al. Among authors: kuramoto k. Anticancer Res. 2015 Dec;35(12):6607-14. Anticancer Res. 2015. PMID: 26637876

10

The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.

Okada M, Kuramoto K, Takeda H, Watarai H, Sakaki H, Seino S, Seino M, Suzuki S, Kitanaka C. Okada M, et al. Among authors: kuramoto k. Oncotarget. 2016 May 10;7(19):27021-32. doi: 10.18632/oncotarget.8395. Oncotarget. 2016. PMID: 27027242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters